>PROKKA_00001 hypothetical protein
MKKCPVCKTDIKEIEPGVYKCLCGYREIQADEESAVEIRLYNHKTSQVFYKNLTVNEIMQ
IDNILKGIEWE*
>PROKKA_00002 hypothetical protein
MHLKTMKVIEFPKNKMVKDKMKKYKLETAIMMLEVLVDYDFTIVVNPKAAENIFSLPKNK
LIENFIITTDINKAEKLEIKKPCYYQLTGNELT*
>PROKKA_00003 hypothetical protein
METKDYGEIPYTIEIDWINETVWLNNHVAKEKIVVTEKDSKSIENAFKLIKAKRNGLF*
>PROKKA_00004 hypothetical protein
MNETIVKGMFRMNKTKIKSIIVSIVLVSSLFIVSGCNLLENEYKQLQEHFKGRNAIITTY
DKESKPLDRIEGKSISISLDDKFKEQDEKGETIKKSSVLNITVGNNQIIHVGSSLILQED
GLQDLMKDTLKTTEIINQDKSRPFLRNIVDSYKNITSGKKRVILIRSQDGKPLATFVGDN
VSYFATDIPKSTGILIDGKYLLIYRCDYTIYDMDLIR*
>PROKKA_00005 Modification methylase RsrI
LLEVNNIYLGNCLEIMKKIDDKSIDMVLSDLPFGMTNNEWDKAIPFEPMWQEINRIAKDN
ASIALMAAGVFTSELVVSNKKYYRYSWIWKPKEKSNFLNANRMPLRQHIDIPIFYKNLPV
YNPQKTYGHKPVKKYKQHTTAGANYGKTKIGMEGGGQTDRYPTTIIDIPYNTIKIKDRIH
PTQKPIELYEYLIKTYTNEEGIALDFTAGSCVLAEACINTNRNYICIEKEKKYCNKAKER
IKLHLEKGKQLKII*
>PROKKA_00006 hypothetical protein
MFWFDKENKDVIFMDNRELEDTLCDGRKLIIEPDILGDFRNIPYKDNTFKLVVFDPPHLI
KAGGNSWLAKKYGKLNSDWPIDIRQGFNECMRVLDKYGILIFKWNEEQIKIKDILKVIDY
KPLLGNKRAKTHWLVFMKK*
>PROKKA_00007 hypothetical protein
MKKYELVIENPTDAFILDKEKNKIIALCNTKRPDLRFNELKNLIEKANKNTKQLFQLGDI
AYMIDEDYRFFESEVCSIELKNGKYYYNTHDCDFEDKDIGDWVFESEMYRELHLEAMM*
>PROKKA_00008 hypothetical protein
MKVKLIGENKTEVQFSNKKEGNLINQLKFFGAVPTKESSLYTYFQFNGDIQATMDNFGFR
I*
>PROKKA_00009 hypothetical protein
MIKTKLFTGVTVLEAVYDYQDFIKRNQNLEIISVNILKDNFVLLTYKMFKEDIKG*
>PROKKA_00010 hypothetical protein
MISIKRKDEIWNAIYAEPCLLDFNTLNTEELSFAIGIIISAGSRNSFKEDHFNKEQLKFL
KKVFKELLKL*
>PROKKA_00011 Botulinum neurotoxin type B precursor
MPVTINNFNYNDPIDNNNIIMMEPPFARGTGRYYKAFKITDRIWIIPERYTFGYKPEDFN
KSSGIFNRDVCEYYDPDYLNTNDKKNIFLQTMIKLFNRIKSKPLGEKLLEMIINGIPYLG
DRRVPLEEFNTNIASVTVNKLISNPGEVERKKGIFANLIIFGPGPVLNENETIDIGIQNH
FASREGFGGIMQMKFCPEYVSVFNNVQENKGASIFNRRGYFSDPALILMHELIHVLHGLY
GIKVDDLPIVPNEKKFFMQSTDAIQAEELYTFGGQDPSIITPSTDKSIYDKVLQNFRGIV
DRLNKVLVCISDPNININIYKNKFKDKYKFVEDSEGKYSIDVESFDKLYKSLMFGFTETN
IAENYKIKTRASYFSDSLPPVKIKNLLDNEIYTIEEGFNISDKDMEKEYRGQNKAINKQA
YEEISKEHLAVYKIQMCKSVKAPGICIDVDNEDLFFIADKNSFSDDLSKNERIEYNTQSN
YIENDFPINELILDTDLISKIELPSENTESLTDFNVDVPVYEKQPAIKKIFTDENTIFQY
LYSQTFPLDIRDISLTSSFDDALLFSNKVYSFFSMDYIKTANKVVEAGLFAGWVKQIVND
FVIEANKSNTMDKIADISLIVPYIGLALNVGNETAKGNFENAFEIAGASILLEFIPELLI
PVVGAFLLESYIDNKNKIIKTIDNALTKRNEKWSDMYGLIVAQWLSTVNTQFYTIKEGMY
KALNYQAQALEEIIKYRYNIYSEKEKSNINIDFNDINSKLNEGINQAIDNINNFINGCSV
SYLMKKMIPLAVEKLLDFDNTLKKNLLNYIDENKLYLIGSAEYEKSKVNKYLKTIMPFDL
SIYTNDTILIEMFNKYNSEILNNIILNLRYKDNNLIDLSGYGAKVEVYDGVELNDKNQFK
LTSSANSKIRVTQNQNIIFNSVFLDFSVSFWIRIPKYKNDGIQNYIHNEYTIINCMKNNS
GWKISIRGNRIIWTLIDINGKTKSVFFEYNIREDISEYINRWFFVTITNNLNNAKIYING
KLESNTDIKDIREVIANGEIIFKLDGDIDRTQFIWMKYFSIFNTELSQSNIEERYKIQSY
SEYLKDFWGNPLMYNKEYYMFNAGNKNSYIKLKKDSPVGEILTRSKYNQNSKYINYRDLY
IGEKFIIRRKSNSQSINDDIVRKEDYIYLDFFNLNQEWRVYTYKYFKKEEEKLFLAPISD
SDEFYNTIQIKEYDEQPTYSCQLLFKKDEESTDEIGLIGIHRFYESGIVFEEYKDYFCIS
KWYLKEVKRKPYNLKLGCNWQFIPKDEGWTE*
>PROKKA_00012 Botulinum neurotoxin type A precursor
MCVEINLGGWLDMNINDNLSINSPVDNKNVVVVRARKTDTVFKAFKVAPNIWVAPERYYG
ESLSIDEEYKVDGGIYDSNFLSQDSEKDKFLQAIITLLKRINSTNAGEKLLSLISTAIPF
PYGYIGGGYYAPNMITFGSAPKSNKKLNSLISSTIPFPYAGYRETNYLSSEDNKSFYASN
IVIFGPGANIVENNTVFYKKEDAENGMGTMTEIWFQPFLTYKYDEFYIDPAIELIKCLIK
SLYFLYGIKPSDDLVIPYRLRSELENIEYSQLNIVDLLVSGGIDPKFINTDPYWFTDNYF
SNAKKVFEDHRNIYETQIEGNNAIGNDIKLRLKQKFRININDIWELNLNYFSKEFSIMMP
DRFNNALKHFYRKQYYKIDYPENYSINGFVNGQINVQLSLSDRNQDIINKPEEIINLLNG
NNVSLMRSNIYGDGLKSTVDDFYSNYKIPYNRAYEYHFNNSNDSSLDNVNIGVIDNIPEI
IDVNPYKENCDKFSPVQKITSTREINTNIPWPINYLQAQNTNNEKFSLSSDFVEVVSSKD
KSLVYSFLSNVMFYLDSIKDNSPIDTDKKYYLWLREIFRNYSFDITATQEINTDCGINKV
VTWFGKALNILNTSDSFVEEFQNLGPISLINKKENLSMPIIEIYGIPNDMLGLPLNDLNE
KLFNIYLKNILYFKKVYFNFLDQWWTEYYSQYFDLICMAKQSILAQEKLIKQIIQNKLQD
LFKADISMDKLNLMNLATEKTFIDLSNESQIAINNINDFLNKSAICVFDTNIYPKFISFM
EQCINSVNSNVTAFIQKCTNITEDEKLQLIKLNTFMNIDFEFFDIQSIKDLITSETDLIK
EEKESDYNLFLFTLQEDNNKVIEDISGKNTLVKYSDSISLVYGVNGDALYLKEPDESVSF
SNKAFENGLTNSFSICFWLRNLGEDIITSKLIENKADNCGWEIYFENNGLVFSIVDCNGN
EENIYLSDVISKNWYYISISIDRLRNQLLIFINDKLIANQSIEQILNIYSSNTISLVNEN
NPIYIEGLSILNRSITSEEVVNNYFSYLNNSYIRDISGERLEYNKTYELYNYVFPENSLY
EVTENNNIYLSIKDTNNLNIQGAKFKLINIDANKQYVQKWDEGVVCLLGDEEKYVDISSE
NNRIQLVNSKDTAKRIIFNNDIFMPNCLTFAYNNKYLSLSLRDRNYNWMICNNNDNIPKA
AHLWALKGI*
>PROKKA_00013 transcriptional regulator BotR, P-21
MNKLFLQIEMLKNDNEEFQEIFKHFEKTINIFTRKYNIYDNYNDILYHLWYTLKKVDLSN
FNTQNDLERYISRTLKRYCLDICNKRKIDKKIIYNSEIADKKLSLIANSYSSYSEFEFND
LISILPDDQKKIIYMKFVEDIKEIDIAKKLNISRQSVYKNKIMALERLEPILKKLINM*
>PROKKA_00014 hypothetical protein
MEHYSTIQNSLNDKIVTISCKANTDLFFYQVPGNGNVSLFQQTRNYLERWRIIYDSNKAA
YKIKSMNIYNTNLVLTWNAPTHNISAQQDSNADNQYWLLLKDIGNNSFIIASYKNPNLVL
YADTVARNLKLSTLNNSSYIKFIIEDYVISDFKNFTCRISPILAGGKVVQQVSMTNLAVN
LYIWNNDLNQKWTIIYNEEKAAYQFFNKILSNGVLTWIFSDGNTVRVSSSAQNNDAQYWL
INPVSDNYDRYTITNLRDKTKVLDLYGGQTADGTTIQVFNSNGGDNQIWTMSNP*
>PROKKA_00015 HA 17 kDa subunit
MSAERTFLPNGNYNIKSIFSGSLYLSPVSGSLTFSNESSANNQKWNVEYMAENRCFKISN
VAEPNKYLSYDNFGFISLDSLSNRCYWFPIKIAVNTYIMLSLNKVNELDYAWDIYDTNEN
ILSQPLLLLPNFDIYNSNQMFKLEKI*
>PROKKA_00016 Hemagglutinin components HA-22/23/53 precursor
MNSSIKKIYNHIQEKVINYSDTIDLADGNYVVSRGDGWILSRQNQILGGSVISNGSTGIV
GDLRVNDNAIPYYYPTPSFNEEYIKNNIQTVFANFTEANQIPIGFEFSKTAPSNKNLYMY
LQYTYIRYEIIKVLQHEIIERAVLYVPSLGYVKSIEFNPGEKINKDFYFLTNDKCILNEQ
FLYKKILETTKNIPTNNIFNSKVSSTQRVLPYSNGLYVINKGDGYIRTNDKDLIGTLLIE
AGSSGSIIQPRLRNTTRPLFTTSNDAKFSQQYTEERLKDAFNVQLFNTSTSLFKFVEEAP
SNKNICIKAYNTYEKYELIDYQNGSIVNKAEYYLPSLGYCEVTNAPSPESEVVKTQVAED
GFIQNGPEEEIVVGVIDPSENIQEINTAISDNYTYNIPGIVNNNPFYILFTVNTTGIYKI
NAQNNLPSLKIYEAIGSGNRNFQSGNLCDDDIKAINYITGFDSPNAKSYLVVLLNKDKNY
YIRVPQTSSNIENQIKFKREEGDLRNLMNSSVNIIDNLNSTGAHYYTRQSPDVHDYISYE
FTIPGNFNNKDTSNIRLYTSYNQGIGTLFRVTETIDGYNLINIQQNLNLLNSTKSIRLLN
GAIYILKVEVTELNNYNIKLHIDITN*
>PROKKA_00017 hypothetical protein
MCDKKYIIEFLIYLSIVILVIIISSEVCMYTFNFKQIIIRLI*
>PROKKA_00018 hypothetical protein
MKIKHPKVNEYYNYLKESFANVNLSEEHRMDIYKRIEIIEALVGLYEQKYEFDDEIIEDL
KLKYRPVFPEELKNIQKNLEKTIIK*
>PROKKA_00019 hypothetical protein
MDIPDIPEYLIETIFENIDQRLKQNFYNFYENLFNMNNKEENLKLLIKDIIQKEFMVAEL
TKISDMDLHKTKHTFIAPDKINKLKRYNLQQIKQTKKRWYNSLFKKKKTNPFNIEIETAN
NNITLYGPEVFFNLYKVRSIEELKDIRAAQFKDWLDNSIFITDFFYLKSKTNKQINTAFN
LDFIYNICTIIYDKWNNNLNFIYMEYPKLLLDHPLVADGSGKIKVHKQTIIQQNQSNKDV
KYKYNDYVSKDGITRILVPESNIDTKQSRLIDNKDLNILSNILKYKKADFLTNKTIVFNL
IDIINNIYCSKTVRSYEDLRNRIAKMTLLKFNFFRTDNTSGIPDAVYGIFSSYEYLDKSQ
NRVKVYVDSILYDKILKNQVYTIYNDKINQLNDDFAKTLVIYLQQEKLVLYTQGKNTTFL
SYDYFSNLVRFRYKKEERNYKIIAQALENMKCNNIIIRDFKKHMNGFIITFLDTNQFEIS
DLFSNKNTSDIIPMI*
>PROKKA_00020 hypothetical protein
MALAIEKLFFNVSKNLIHFITEPIPLYHYKTISFNKCCYCPFYKKMNDKNIHNYCSNYCN
NKYKKVIKKYNIYSNINIDKTHIQFSLTQIKQMLIYYYYANSKGFVSLISKKRIAKMIGC
CEKTVDINNKLFSDLGLILISGTINNKFSLIIKDYSEHYSKNNAGYLNLATNVFKDLLHI
NNVNALRIALQGILKHDINTILDRETYFSINSMKAFLPEYINCKSAIEKIICKLNSNTIT
MLFNSSEKLIFVISKNLHGKLLKKEMYYKYKNNFLNYITENNIKLNNLSHSINNIVKLSF
EYGYDIVQLMLGEIKDIAPTIFNVGGYIRDKIKRYIYMNEPFFAI*
>PROKKA_00021 hypothetical protein
MEILYYVNNETNSLLVTTEEKDHMHYIKTNKKDFLKYKKAGYAIITSAEMDFDLCLKMFS
PTFKEKIINIIKKAIQNEYIIAEKRTDNKYTISVIDSNFKLVL*
>PROKKA_00022 DNA-directed RNA polymerase subunit alpha
MILGGNKKMRKNKRDELRELNLSIRAYNSLRNMGINTLEDLSMYSKKQLYQFKGIGIVSL
RKIEKGLDKKNMKMEAV*
